This study aimed to test the hypothesis that baseline levels of urinary MCP-1 and EGF or their ratio would predict rapid decline of estimated GFR in a cohort of T2DM patients with CKD independent of conventional clinical risk factors. Here, EGF is linked to chronic kidney disease.